ZEVRA THERAPEUTICS, INC. (ZVRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 11.5M Q4 '19: 1.4M Q1 '20: 2.1M Q2 '20: 6.9M Q3 '20: 1.9M Q4 '20: 2.4M Q1 '21: 12.1M Q2 '21: 12M Q3 '21: 2M Q4 '21: 2.6M Q1 '22: 4M Q2 '22: 1.3M Q3 '22: 2.9M Q4 '22: 2M Q1 '23: 3.2M Q2 '23: 8.5M Q3 '23: 2.9M Q4 '23: 12.9M Q1 '24: 3.4M Q2 '24: 4.4M Q3 '24: 3.7M Q4 '24: 12M Q1 '25: 20.4M Q2 '25: 25.9M Q3 '25: 26.1M Q4 '25: 34.1M Q1 '26: 36.2M Q2 '26: 39.7M Q1 '15 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit Quarterly

-15M 0 15M 30M 45M Q1 '23: 3M Q2 '23: 7.7M Q3 '23: 2.7M Q4 '23: 10.9M Q1 '24: 1.7M Q2 '24: -686K Q3 '24: -225K Q4 '24: 9M Q1 '25: 17.4M Q2 '25: 11.9M Q3 '25: 24.4M Q4 '25: 32.2M Q1 '26: 34M Q2 '26: 37.8M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q1 '14: -1.6M Q2 '14: -3M Q3 '14: -4.3M Q4 '14: -7.5M Q1 '15: -3.1M Q2 '15: -6M Q3 '15: -6.5M Q4 '15: -7.3M Q1 '16: -7M Q2 '16: -9.3M Q3 '16: -10.4M Q4 '16: -10.8M Q1 '17: -7.4M Q2 '17: -8.2M Q3 '17: -9.6M Q4 '17: -8.2M Q1 '18: -14.8M Q2 '18: -13.9M Q3 '18: -18M Q4 '18: -9.3M Q1 '19: -11.4M Q2 '19: -7.8M Q3 '19: 3.2M Q4 '19: -4.4M Q1 '20: -3.8M Q2 '20: 2.6M Q3 '20: -1.2M Q4 '20: -3.2M Q1 '21: 7M Q2 '21: 5.8M Q3 '21: -2.2M Q4 '21: -2.8M Q1 '22: -1.9M Q2 '22: -24.8M Q3 '22: -6.6M Q4 '22: -9.3M Q1 '23: -12.8M Q2 '23: -6.3M Q3 '23: -15.4M Q4 '23: -15.2M Q1 '24: -20.5M Q2 '24: -23.8M Q3 '24: -27.3M Q4 '24: -15.4M Q1 '25: -5.4M Q2 '25: -71M Q3 '25: 4.1M Q4 '25: 9.3M Q1 '26: 52.1M Q2 '26: 16.8M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income Quarterly

-60M -30M 0 30M 60M 90M Q1 '14: -1.9M Q2 '14: -3.6M Q3 '14: -7.1M Q4 '14: -11.8M Q1 '15: -6M Q2 '15: -29.7M Q3 '15: -9.7M Q4 '15: -9.2M Q1 '16: -2.9M Q2 '16: 9.8M Q3 '16: -13.4M Q4 '16: -9.9M Q1 '17: -16.3M Q2 '17: -6.5M Q3 '17: -10M Q4 '17: -10.6M Q1 '18: -26.2M Q2 '18: -10M Q3 '18: -15.1M Q4 '18: -5.2M Q1 '19: -12.3M Q2 '19: -9.3M Q3 '19: 3.1M Q4 '19: -6M Q1 '20: -5.8M Q2 '20: 859K Q3 '20: -3M Q4 '20: -4.9M Q1 '21: -10.3M Q2 '21: 6.2M Q3 '21: -1.8M Q4 '21: -2.7M Q1 '22: -1.9M Q2 '22: -24M Q3 '22: -6.6M Q4 '22: 5.8M Q1 '23: -13.2M Q2 '23: -2.6M Q3 '23: -10.4M Q4 '23: -19.9M Q1 '24: -16.6M Q2 '24: -19.9M Q3 '24: -33.2M Q4 '24: -35.7M Q1 '25: -3.1M Q2 '25: 74.7M Q3 '25: -544K Q4 '25: 12.2M Q1 '26: 37.9M Q2 '26: 8.8M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue Quarterly

0 5M 10M 15M Q3 '19: 1M Q4 '19: 9M Q2 '21: 1M Q3 '21: 0 Q4 '21: 59K Q1 '22: 8K Q2 '22: 51K Q3 '22: 141K Q4 '22: 22K Q1 '23: 125K Q2 '23: 677K Q3 '23: 144K Q4 '23: 1.2M Q1 '24: 175K Q2 '24: 3.6M Q3 '24: 2.3M Q4 '24: 1.4M Q1 '25: 1.3M Q2 '25: 12.4M Q3 '25: 1.2M Q4 '25: 1.5M Q1 '26: 1.9M Q2 '26: 1.5M Q4 '19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '14: -888K Q2 '14: -2.9M Q3 '14: -3.9M Q4 '14: -7M Q1 '15: -4M Q2 '15: -5.3M Q3 '15: -4.6M Q4 '15: -6.4M Q1 '16: -3.9M Q2 '16: -8.3M Q3 '16: -8M Q4 '16: -9.4M Q1 '17: -9.5M Q2 '17: -6.5M Q3 '17: -10.2M Q4 '17: -6.9M Q1 '18: -14.1M Q2 '18: -9.2M Q3 '18: -16M Q4 '18: -15M Q1 '19: -11.1M Q2 '19: -7.3M Q3 '19: -2.2M Q4 '19: -3.1M Q1 '20: -2M Q2 '20: 2.2M Q3 '20: -1.1M Q4 '20: -1.1M Q1 '21: -2.6M Q2 '21: 16.6M Q3 '21: -2.7M Q4 '21: -848K Q1 '22: -3.6M Q2 '22: -4.1M Q3 '22: -6.6M Q4 '22: -4.5M Q1 '23: -4M Q2 '23: -8.7M Q3 '23: -4.6M Q4 '23: -16.2M Q1 '24: -16.2M Q2 '24: -19.1M Q3 '24: -18.1M Q4 '24: -16.2M Q1 '25: -8.2M Q2 '25: -3.6M Q3 '25: 4.7M Q4 '25: 5.5M Q1 '26: 6.1M Q2 '26: 17M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '14: -892K Q2 '14: -2.9M Q3 '14: -3.9M Q4 '14: -7M Q1 '15: -4M Q2 '15: -5.3M Q3 '15: -4.7M Q4 '15: -6.4M Q1 '16: -3.9M Q2 '16: -8.4M Q3 '16: -8.3M Q4 '16: -9.4M Q1 '17: -9.6M Q2 '17: -6.5M Q3 '17: -10.2M Q4 '17: -6.9M Q4 '18: -15M Q1 '19: -11.1M Q2 '19: -7.3M Q3 '19: -2.2M Q4 '19: -3.1M Q1 '20: -2M Q2 '20: 2.2M Q3 '20: -1.1M Q4 '20: -1.1M Q1 '21: -2.6M Q2 '21: 16.5M Q3 '21: -2.7M Q4 '21: -865K Q1 '22: -3.6M Q2 '22: -4.1M Q3 '22: -6.6M Q4 '22: -4.5M Q1 '23: -4.1M Q2 '23: -8.7M Q3 '23: -4.8M Q4 '23: -16.2M Q1 '24: -16.2M Q2 '24: -19.1M Q3 '24: -18.1M Q4 '24: -16.2M Q1 '25: -8.3M Q2 '25: -3.8M Q3 '25: 4.2M Q4 '25: 5.5M Q1 '26: 6.1M Q2 '26: 16.8M Q1 '15 Q3 '16 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '15: 12.2M Q2 '16: 15.4M Q2 '17: 14.6M Q2 '18: 16.5M Q3 '18: 16M Q2 '19: 28.4M Q3 '19: 31.7M Q2 '20: 3.9M Q3 '20: 4.4M Q1 '21: 19.1M Q2 '21: 29.2M Q3 '21: 35.2M Q1 '22: 34.5M Q2 '22: 34.4M Q3 '22: 34.5M Q1 '23: 34.5M Q2 '23: 33.9M Q3 '23: 34.7M Q1 '24: 41.8M Q2 '24: 41.9M Q3 '24: 47.8M Q1 '25: 54.1M Q2 '25: 56.3M Q3 '25: 56M Q1 '26: 60.2M Q2 '26: 61.3M Q2 '16 Q2 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '14: -10.27 Q1 '15: -11.97 Q2 '15: -12.92 Q3 '15: -10.60 Q4 '15: -6.27 Q1 '16: -3.97 Q2 '16: -2.10 Q3 '16: -2.34 Q4 '16: -2.38 Q1 '17: -3.29 Q2 '17: -3.15 Q3 '17: -2.91 Q4 '17: -2.95 Q1 '18: -3.61 Q2 '18: -4.08 Q3 '18: -4.34 Q4 '18: -3.15 Q1 '19: -1.84 Q2 '19: -1.26 Q3 '19: -0.26 Q4 '20: -3.52 Q1 '22: 0.33 Q2 '22: 0.03 Q3 '22: -0.10 Q4 '22: -0.78 Q1 '23: -1.11 Q2 '23: -0.49 Q3 '23: -0.60 Q4 '23: -1.30 Q1 '24: -1.32 Q2 '24: -1.72 Q3 '24: -2.11 Q4 '24: -2.26 Q1 '25: -1.92 Q2 '25: -0.23 Q3 '25: 0.45 Q4 '25: 1.33 Q1 '26: 1.99 Q2 '26: 0.92 Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.